Showing results (1171-1180 of 1,210) with videos related to

Sort By:
Pageof 121
Elife|September 10, 2025
Human cytomegalovirus infection coopts chromatin organization to diminish TEAD1 transcription factor activityKhund Sayeed, Sreeja Parameswaran, Matthew J Beucler, et al.
Oral Oncology|February 17, 2026
Defining response-adapted surgery after neoadjuvant systemic therapy in sinonasal squamous cell carcinomaJennifer R Cracchiolo, Fergal Kavanagh, Michael T Starc, et al.
BMC Genomics|March 13, 2024
Shared and distinct interactions of type 1 and type 2 Epstein-Barr Nuclear Antigen 2 with the human genomeKenyatta C M F Viel, Sreeja Parameswaran, Omer A Donmez, et al.
The American Surgeon|April 19, 2022
Endovascular Intervention in Internal Carotid Artery Blunt Cerebrovascular Injury: An EAST Multicenter StudyMargaret Lauerman, Emily Esposito, Chance Spalding, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Comparison of PU.1 genomic binding across immune cells reveals cell type-specific roles in autoimmune diseaseDavid A Lewis, Molly S Shook, Lucinda P Lawson, et al.
The American Surgeon|June 2, 2022
Grade 1 Internal Carotid Artery Blunt Cerebrovascular Injury Persistence Risks Stroke With Current Management: An EAST Multicenter StudySarah Yang, Emily Esposito, Chance Spalding, et al.
The AAPS Journal|June 26, 2014
Small molecule specific run acceptance, specific assay operation, and chromatographic run quality assessment: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamsEric J Woolf, Stuart McDougall, Douglas M Fast, et al.
Journal for Immunotherapy of Cancer|June 20, 2020
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosingDanny Rischin, Michael R Migden, Annette M Lim, et al.
Nature Medicine|August 24, 2023
Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trialJoris L Vos, Bharat Burman, Swati Jain, et al.
Cancer|July 9, 2020
The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancerJung Julie Kang, Richard J Wong, Eric J Sherman, et al.
Pageof 121